Farxiga (dapagliflozin)
Farxiga can be used to treat heart failure and type 2 diabetes. It was approved by the FDA in 2014. The dosage depends on the condition and its severity. For example, 5-10 mg per day is the standard dose for type 2 diabetes and 10 mg per day for heart failure. The drug is used to:
- Reduce the risk of further worsening of kidney disease and slow the progression toward end-stage kidney disease
- Improve management of blood sugar
- Make you less susceptible to cardiovascular death. It also reduces the risk of getting hospitalized for heart failure with a decreased ejection fraction
- Decrease the chances of getting hospitalized for heart failure in adults who have an underlying cardiovascular disease